FDA announcements and drug approval records

Google DeepMind Advances AI in Drug Discovery with AlphaFold Following Nobel Prize in Chemistry for Demis Hassabis and John Jumper

Oct 15, 2024, 08:30 AM

Google DeepMind is advancing artificial intelligence (AI) to transform scientific discovery, particularly in drug design and protein structure prediction. The company's initiatives include the use of AlphaFold, a technology that predicts protein shapes, which has gained attention following the recent Nobel Prize in Chemistry awarded to its creators, Demis Hassabis and John Jumper. Experts, including Fiona H. Marshall, have highlighted the role of AlphaFold in accelerating the drug discovery process, emphasizing its potential to enable next-generation structure-based drug design. Additionally, companies are increasingly utilizing machine learning to refine drug development strategies by focusing on specific characteristics rather than broad searches. This shift is expected to enhance the efficiency and success rates of the drug-discovery process, marking a significant evolution in the field of biology and medicine.